Compound information
- Natural Products
- ZC1008144
- Molecular Formula
- C18H24N2O4S
- Molecular Weight
- 364.145678248 g/mol
- Structure
-
- IUPAC Name
- N-[3-[(3S)-3-methylsulfonylazocane-1-carbonyl]phenyl]prop-2-enamide
- InChI
- InChI=1S/C18H24N2O4S/c1-3-17(21)19-15-9-7-8-14(12-15)18(22)20-11-6-4-5-10-16(13-20)25(2,23)24/h3,7-9,12,16H,1,4-6,10-11,13H2,2H3,(H,19,21)/t16-/m0/s1
- InChI Key
- YZZOCTGHSJOFLJ-INIZCTEOSA-N
- SMILES
- C=CC(=O)Nc1cccc(C(=O)N2CCCCC[C@H](S(C)(=O)=O)C2)c1
- Source
- ZINC002325888065
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 25 | Ring Count | 2 |
| Heteroatom Count | 7 | Rotatable Bond Count | 4 |
| Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 83.55 Å2 | LogP | 1.728 |
| LogS | -3.108 | LogD | 1.247 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.09 | Pgp substrate | 0.913 |
| HIA | 0.967 | F20 % | 0.978 |
| F30 % | 0.123 | Caco-2 | -5.034 |
| MDCK | -5.147 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.869 | PPB | 74.596 |
| VD | 0.937 | Fu | 1.036 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.006 | CYP1A2 substrate | 0.595 |
| CYP2A6 substrate | 0.74 | CYP2B6 substrate | 0.718 |
| CYP2C19 inhibitor | 0.321 | CYP2C19 substrate | 0.898 |
| CYP2C8 substrate | 0.693 | CYP2C9 inhibitor | 0.079 |
| CYP2C9 substrate | 0.969 | CYP2D6 inhibitor | 0.003 |
| CYP2D6 substrate | 0.894 | CYP2E1 substrate | 0.864 |
| CYP3A4 inhibitor | 0.093 | CYP3A4 substrate | 0.993 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.495 | CL | 0.475 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.012 | Hepatotoxicity | 0.847 |
| Mutagenicity | 0.021 | Rat Oral Acute Toxicity | 0.033 |
| FDAMDD | 0.52 | Skin Sensitization | 0.595 |
| Carcinogenicity | 0.055 | Eye Corrosion | 0.005 |
| Eye Irritation | 0.623 | Respiratory Toxicity | 0.028 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.028 | IGC50 | 2.977 |
| LC50FM | 3.167 | LC50DM | 0.241 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.214 | NR-AR-LBD | 0.196 |
| NR-AhR | 0.005 | NR-Aromatase | 0.05 |
| NR-ER | 0.355 | NR-ER-LBD | 0.368 |
| NR-PPAR-gamma | 0.339 | SR-ARE | 0.777 |
| SR-ATAD5 | 0.426 | SR-HSE | 0.196 |
| SR-MMP | 0.111 | SR-p53 | 0.039 |
Similar covalent drugs
No similar covalent drugs found for this compound.